BRIEF-EU health agency recommends approval of new hepatitis C drugs By: Reuters: Company News May 27, 2016 at 07:21 AM EDT * Recommends against approval of Takeda Pharmaceutical Co Ltd's ixazomib to treat multiple myeloma Read More >> Related Stocks: Astrazeneca Plc ADR Gilead Sciences Johnson & Johnson Merck & Co